Related Experiment Video
Updated: Sep 16, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Optimal model-based insulin bolus advisor for subjects with type 1 diabetes using continuous glucose monitoring
Martin Dodek1, Eva Miklovičová1
1Institute of Robotics and Cybernetics, Faculty of Electrical Engineering and Information Technology Slovak University of Technology in Bratislava, Ilkovičova 3, Bratislava, 841 04, Slovakia.
Abstract:
This paper presents an optimal model-based bolus advisor aimed at improving insulin therapy for individuals with type 1 diabetes who actively utilize continuous glucose monitoring systems. The proposed approach serves as an advanced advisory system, facilitating decision-making for insulin administration. Unlike traditional artificial pancreas systems, which rely on continuous insulin delivery and equidistant control decisions at each sampling interval, this bolus advisor considers sparse and impulse-like insulin administration without the basal component, solely disturbance-triggered to optimally reject the carbohydrate intake. This bolus advisor generates personalized recommendations for the timing and dosage of insulin administration, informed by real-time glycemia measurements. The methodology considers a linear discrete-time state space model and an optimization problem based on a quadratic summation criterion to minimize the area of deviation of the preprandial-postprandial glycemia response from the target glycemia response. It can be seen as a constrained bivariate optimization problem with real-valued and integer decision variables. The proposed algorithm for constrained optimization is based on sequential quadratic interpolation and Karush-Kuhn-Tucker conditions, with the solution obtained by Newton's method. In order to take into account the past input activity and the glycemia measurements, the state of the system is estimated by the Kalman filter and involved in the problem formulation, providing feedback from the subject. The effectiveness of the proposed bolus advisor is validated through simulation experiments, showcasing its potential to enhance glycemic control and improve the overall management of type 1 diabetes.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
One-Compartment Open Model for IV Bolus Administration: General Considerations
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
Two-Compartment Open Model: IV Bolus Administration
The disparity between drug input and the sum of drug transfer rates between...

